Company news
Thalia Therapeutics PLC news in 2020
Thalia Therapeutics PLC's news releases, calls and decks from 2020, newest first.
Placing to raise £2 million
December 9, 2020
Formulation Work Update
December 3, 2020
SP Angel Research Note
November 18, 2020
Launch of Nuvec® Oncology Treatment Programme
November 9, 2020
Covid-19 Proof of Concept Update
September 14, 2020
Exercise of Options
September 8, 2020
Technology Transfer and Manufacturing Contract
September 1, 2020
Exercise of Warrants and Issue of Equity
August 26, 2020
Positive Covid-19 In Vitro Study Results
August 12, 2020
Change of Adviser
July 15, 2020
Work Programme and Strategic Update
July 6, 2020
Result of General Meeting and grant of warrants
June 18, 2020
Posting of circular and notice of general meeting
June 1, 2020
Covid-19 Project Update
May 28, 2020
N4 Pharma: Grant of Options
May 18, 2020
Placing to raise £2m & appointment of Joint Broker
May 13, 2020
New Nuvec® opportunity and patent filing
April 24, 2020
Attendance at the Company's annual general meeting
April 17, 2020
Changes to AGM
March 25, 2020
Posting of Annual Report and Notice of AGM
March 4, 2020
Research Collaboration Agreement
February 11, 2020
Update on Nuvec® process improvements
January 29, 2020